Evidence map›Paper›PMID 25337271›Full record

ArticleInternational journal of clinical and experimental pathology2014

The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.

Lin Jiang, Chaofu Wang, Canlin Sun, Yumin Xu, Zhongqi Ding, Xueling Zhang, Junxing Huang, Hong Yu

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Lack of association betweenBioscience reports · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Lin JiangDepartment of Anesthesiology, Taizhou People's Hospital Taizhou, Jiangsu, China.
Chaofu WangDepartment of Pathology, Shanghai Cancer Center Fudan University Shanghai, China.
Canlin SunDepartment of Anesthesiology, Taizhou People's Hospital Taizhou, Jiangsu, China.
Yumin XuDepartment of Anesthesiology, Taizhou People's Hospital Taizhou, Jiangsu, China.
Zhongqi DingDepartment of Nuclear Medicine, Taizhou People's Hospital Taizhou, Jiangsu, China.
Xueling ZhangDepartment of Thoracic Surgery, Taizhou Central Hospital Taizhou, Zhejiang, China.
Junxing HuangDepartment of Oncology, Taizhou People's Hospital Taizhou, Jiangsu, China.
Hong YuDepartment of Oncology, Taizhou People's Hospital Taizhou, Jiangsu, China ; Department of Pathology, Taizhou People's Hospital Taizhou, Jiangsu, China.
Nantong University · CNFudan University Shanghai Cancer Center · CNTaizhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNA-218 (miR-218) acts as a tumor suppressor in numerous types of cancer by regulation of the expression of target genes. The aim of this study was to investigate whether polymorphisms in miR-218 LAMB3 pathway were associated with the risk and prognosis of esophageal squamous cell carcinoma (ESCC). Pri-mir-218 rs11134527 and LAMB3 rs2566 were genotyped in ESCC patients and 745 controls to assess their associations with cancer risk and overall survival. Pri-mir-218 rs11134527 was significantly associated with a decreased risk of ESCC under codominant, recessive and additive models. Although there was a significant association between rs11134527 and better survival of ESCC patients under codominant, recessive and additive models, the association disappeared after adjustment for TNM and LNM. However, further stratified analysis revealed that the association remained significant in patients with TNM stages I and II or non-LNM. Our data suggest that pri-miR-218 rs11134527 may contribute to the genetic susceptibility and prognosis for ESCC in Chinese Han population.

Indexed as

Polymorphism, Single NucleotideAgedAsian PeopleBiomarkers, TumorCarcinoma, Squamous CellCase-Control StudiesCell Adhesion MoleculesChinaEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleGenetic Predisposition to DiseaseHumansKalininKaplan-Meier EstimateMaleBiomarkers, TumorCell Adhesion MoleculesKalininMicroRNAsMIRN218 microRNA, humanEsophageal squamous cell carcinomalaminin 5miR-218single nucleotide polymorphismsusceptibility

Identifiers

PMID25337271
PMCPMC4203242
OpenAlexW2223736629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.